Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
92.53
-1.78 (-1.89%)
Sep 9, 2026, 1:46 PM EDT - Market open
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $175 | Buy | Maintains | $175 | +89.13% | Sep 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +29.69% | Sep 3, 2026 |
| UBS | UBS | Buy Maintains $130 | Buy | Maintains | $130 | +40.49% | Sep 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +94.53% | Aug 17, 2026 |
| Wedbush | Wedbush | Buy Maintains $165 | Buy | Maintains | $165 | +78.32% | Aug 12, 2026 |
| Jefferies | Jefferies | Buy Maintains $133 | Buy | Maintains | $133 | +43.74% | Aug 11, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $200 | Buy | Reiterates | $200 | +116.15% | Aug 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.